Impact of Coronary Artery Disease on 30‐Day and 1‐Year Mortality in Patients Undergoing Transcatheter Aortic Valve Replacement: A Meta‐Analysis
Journal of the American Heart Association2017Vol. 6(10)
Citations Over TimeTop 10% of 2017 papers
Kesavan Sankaramangalam, Kinjal Banerjee, Krishna Kandregula, Divyanshu Mohananey, Akhil Parashar, Brandon Jones, Yash Jobanputra, Stephanie Mick, Amar Krishnaswamy, Lars G. Svensson, Samir Kapadia
Abstract
Even though coexisting CAD does not impact 30-day mortality, it does have an impact on 1-year mortality in patients undergoing TAVR. Our results highlight a need to revisit the revascularization strategies for concomitant CAD in patients with TAVR.
Related Papers
- → Bleeding Complications After Surgical Aortic Valve Replacement Compared With Transcatheter Aortic Valve Replacement(2013)189 cited
- → Is Transcatheter Aortic Valve Replacement Superior to Surgical Aortic Valve Replacement?(2017)16 cited
- → Surgical versus transcatheter aortic valve replacement: Impact of patient‐prosthesis mismatch on outcomes(2022)5 cited
- → The Role of Transcatheter Aortic Valve Replacement in Asymptomatic Aortic Stenosis: A Feasibility Analysis(2022)3 cited
- → Surgical Versus Transcatheter Aortic Valve Replacement: Impact of Patient-Prosthesis Mismatch on Outcomes(2022)